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Abstract: Toxoplasmosis is a wide spread disease in our society,moreover it plays an
important role in causation of abortion in pregnant women. The present study was carried out to
evaluate the role of Heat Shock Protein-70(HSP-70) in the immune response against infection with
Toxoplasma gondii among women with  abortion.
The present study was carried out on(35) women ,all of them having abortion and proved by
confirmatory tests that they have an active form of toxoplasma infection. It also included twenty
apparently healthy women as a control group . The patients were between 15 to 50 years of age, blood
samples were collected from them during the period between May 2010 to May 2011. The Cytokines
that were measured among studied groups by ELISA technique included HSP-70,Interleukin-10(IL10)
, Gamma Interferon(IFNγ) and Interleukin-12(IL-12), thereafter cytokines were remeasured after
receiving complete course of treatment.
The study showed a high significant increase in serum level of HSP-70 in patients with IgM
seropositivity (4.138pg/ml) when compared with serum levels in control and post treated groups
(1.990pg/ml , 1.015pg/ml) respectively.It was also found that there was a concomitant  increase in
serum level of HSP-70 and serum level of both IFNγ and IL-12   in the early stage of acute infection
(19.023, 81.292) respectively.
ﮫﺻﻼﺨﻟا:
 ثاﺪﺣا ﻲﻓ ﺎﻤﮭﻣ ارود ﺐﻌﻠﯾ ﮫﻧﻮﻛ ﻰﻠﻋ ةوﻼﻋ، ﺎﻨﺗﺎﻌﻤﺘﺠﻣ ﻲﻓ رﺎﺸﺘﻧﻻا ﺔﻌﺳاﻮﻟا ضاﺮﻣﻻا ﻦﻣ تﺎﺳﻮﻘﻤﻟا ءاد ضﺮﻣ
ا ءﺎﺴﻨﻟا ىﺪﻟ طﺎﻘﺳﻻاﻞﻣاﻮﺤﻟ . رود ﺔﻓﺮﻌﻤﻟ ﮫﺳارﺪﻟا هﺬھ ﺖﯾﺮﺟا)Heat Shock Protein-70 (HSP-70 ﮫﺑﺎﺠﺘﺳﻻا ﻲﻓ
ﺎطﺎﻘﺳا ﻦﯿﻧﺎﻋ ﻲﺗﻼﻟا ءﺎﺴﻨﻟا ىﺪﻟ ضﺮﻤﻟا اﺬھ ﺪﺿ ﮫﯿﻋﺎﻨﻤﻟا.
 مد ﻦﻣ تﺎﻨﯿﻋ ﻊﻤﺟ ﮫﺳارﺪﻟا ﻚﻠﺗ ﺖﻨﻤﻀﺗ)٣٥( ﻦﮭﺘﺑﺎﺻا ﺎﯾﺮﺒﺘﺨﻣ ﺖﺒﺛ يﺬﻟاو ﻰﺿﺮﻤﻟا ﻚﺌﻟوا ﻦﻣ ﻢﺗ ﺎﻤﻛ ضﺮﻤﻟا اﺬﮭﺑ
 ﻦﻣ تﺎﻨﯿﻋ ﻊﻤﺟ)٢٠( ﮫﻋﻮﻤﺠﻤﻛ ءﺎﺤﺻﻻا ءﺎﺴﻨﻟا ﻦﻣﮫﻄﺑﺎﺿ ﻦﯿﺑﺎﻣ ﮫﺳارﺪﻟا ﻚﻠﺗ ﻢﮭﺘﻠﻤﺷ ﻦﻣ رﺎﻤﻋا ﺖﺣواﺮﺗ ،١٥-٥٠  ﮫﻨﺳ
ﺲﯾﺎﻣ ﻦﯿﺑﺎﻣ هﺮﺘﻔﻠﻟو٢٠١٠ ﺲﯾﺎﻣ و٢٠١١ ىﻮﺘﺴﻣ سﺎﯿﻗ ﻢﺗ ﺪﻗوHSP-70و ﻰﺿﺮﻤﻟا ﻚﺌﻟوا ﻞﺼﻣ ﻲﻓﻟاﻟا ﺔﻋﻮﻤﺠﻤﮫﻄﺑﺎﻀ
ﺮﺷﺎﻌﻟا ﻦﯾﺎﻛﻮﺘﯾﺎﺴﻟا ىﻮﺘﺴﻣ سﺎﯿﻗ ﻰﻟا ﮫﻓﺎﺿﻻﺎﺑ)(Interleukin-10ا ﻦﯾﺎﻜﺘﯾﺎﺴﻟا، ﺮﺸﻋ ﻲﻧﺎﺜﻟ)IL-12  (نوﺮﯿﻔﺘﻧا ﺎﻣﺎﻜﻟاو )
Gamma Interfeon ,IFNγ  (مزﻼﻟا جﻼﻌﻟا ﺬﺧا ﺪﻌﺑ ﻦﮭﺳﺎﯿﻗ ﻢﺗ اﺮﯿﺧاو.
تﺮﮭظاﮫﺳارﺪﻟا ﻚﻠﺗ ﺞﺋﺎﺘﻧلا ىﻮﺘﺴﻣ ﻲﻓ ﮫﯾﻮﻨﻌﻣ هرﻮﺼﺑو هدﺎﯾز )HSP-70 (ﻰﺿﺮﻤﻟا ﻚﺌﻟوا مد ﻲﻓ)pg/ml
٤.١٣٨  (ﮫﺑﺎﺻﻻا ﻦﻣ هﺮﻜﺒﻤﻟا ﻞﺣاﺮﻤﻟا ﻲﻓ ﻢھﺬﺧا ﺪﻌﺑ ﻰﺿﺮﻤﻟا ﺔﻋﻮﻤﺠﻣو ﮫﻄﺑﺎﻀﻟا ﮫﻋﻮﻤﺠﻤﻟا ﻲﻓ هاﻮﺘﺴﻤﻟ ﺎﮭﺘﻧرﺎﻘﻣ ﺪﻨﻋ
 مزﻼﻟا جﻼﻌﻟا)pg/ml١.٠١٥,1.990pg/ml (  ىﻮﺘﺴﻣ ﻲﻓ هدﺎﯾﺰﻟا نﺎﺑ ﻦﯿﺒﺗ ﺎﻤﻛ، ﻲﻟاﻮﺘﻟا ﻰﻠﻋوHSP-70 ﻊﻣ ﻖﻓاﺮﺗ
 ىﻮﺘﺴﻣ ﻲﻓ ﮫﻠﺻﺎﺤﻟا هدﺎﯾﺰﻟا )IL-12&IFNγ ( ضﺮﻤﻠﻟ هﺮﻜﺒﻤﻟا ﻞﺣاﺮﻤﻟا ﻲﻓ)pg/ml٨١.٢;19.023 pg/ml (
ﻲﻟاﻮﺘﻟا ﻰﻠﻋو.
INTRODUCTION:
Heat shock proteins (HSPs) was used first to describe Drosophila melanogaster proteins
expressed at elevated temperatures (1). It is a collective term for a number of ubiquitously
expressed and highly conserved cytoprotective eukaryotic and bacterial proteins. In 1962,
Ritossa reported that heat and the metabolic dinitrophenol induced a characteristic pattern of
puffing in the chromosomes of Drosophila ,( 2 ; 3).
This discovery finally led to the identification of the heat-shock proteins (HSP) or stress
proteins . They are named according to their molecular weight. For example, Hsp60, Hsp70
and Hsp90 (the most widely-studied HSPs) refer to families of heat shock proteins on the
order of 60, 70 and 90 kilodaltons in size, respectively ( 4).
The intracellular role of heat shock proteins is that of molecular chaperones. These proteins
stabilize unstable proteins and leading to correct folding, assembly of proteins into oligomeric
structures, transport to subcellular compartments, or controlled switching between active and
inactive conformational states (5).
These proteins are found in the circulation of normal subjects (6) and their concentrations
decline with age (7). Altered serum levels of these proteins have been found in association
with certain disease states (8; 9; 10). Antibodies against various heat shock proteins are also
observed in normal subjects (6) and various disease states (11; 12; 13; 14; 15).
Concerning Heat Shock Protein (HSP-70), it plays an important role in transmembrane
transport of proteins, by stabilizing them in a partially-folded state. Hsp70 proteins can act to
protect cells from thermal or oxidative stress. These stresses cause partial unfolding and
possible aggregation. By temporarily binding to hydrophobic residues exposed by stress,
Hsp70 prevents these partially-denatured proteins from aggregating, and allows them to refold
16).
Heat Shock Protein-70 (Hsp70) seems to be able to participate in disposal of damaged or
defective proteins. (17). In addition to improving overall protein integrity, Hsp 70 directly
inhibits apoptosis , Hsp 70 inhibits this process by blocking the recruitment of procaspase-9 to
the Apoptosis Activating Factor-1(Apaf-1)/dATP/cytochrome c apoptosome complex (18).
MATERIALS AND METHODS:
Collection of Blood Samples:
Thirty five  blood samples were collected from  women with active form of toxoplasmosis
after confirmation with IgM test ,the age was ranged between 16 to 45 years old from different
health centers in Najaf governorate),five ml of venous blood was drawn using a 5 ml size
disposable syringe then transferred to 10 ml disposable sterile serum tube. The blood samples
were left to clot then centrifuged at 3000 rpm for 5 minutes to separate the serum.  Serum
samples transferred to eppendorf tubes and stored at 4 - 8 °C for 24 hrs. If long period of
storage is required, the sera will be kept frozen at – 20 °C until use.
ELISA tests:
The following tests were done according to manufacturer's instructions:
1-IgG and IgM ELISA tests. ( Biocheck/USA)
2-Heat Shock Protein-70 (HSP-70 ). (USBiological)
3-Gamma Interferon (IFN-γ).( Immunotech/France)
4- Interleukin-10 (IL-10). (USBiologica/USA)
5- Interleukin-12 (IL-12). (USBiologica/USA)
RESULTS:
Heat Shock Protein-70 (Hsp-70):
There was a statistically significant difference (P˂0.000) between serum level of HSP-70 in
patients with acute infection (displaying positive IgM antitoxoplasma antibody)
(4.138±1.05847) and serum level in control and post treatment group (1.015±0.630,
1.990±0.961) respectively and there was no significant difference between serum level in
acute state with positive both IgG and IgM antitoxoplasma antibodies (1.1017±0.568) and the
level in control and post treated groups. (Table 1)
Table (1) : Serume hsp-70 levels in study groups.
Cytokine type
Clinical group
Mean concentration ±SD of
Hsp-70
No.(Conc. Pg/ml)
Acute
cases
With positive
IgM only
4.138±1.05847*
With positive
IgM/IgG 1.1017±0.568**
Total 3.271±1.677***
Post treatment 1.990±0.961*  ,**
Control group 1.015±0.630***
P value Paired t-test=7.771   p value=0.000*
Paired t-test=1.421      p value=0.189**
Independent t test=5.768 pvalue=0.000***
*paired t-test between acute (IgM only) group  & post treatment group.
** paired t-test between acute (IgM/IgG) group  & post treatment group.
***Independent t-test between acute group & control group.
IFNγ Level:
A high significant increase (p˂0.000) of serum IFNγ was recorded in acute cases with only
positive IgM antitoxoplasma antibody (19.023±2.881pg/)  when compared with post treatment
and control serum level (3.052±1.416 , 2.211±1.193) ,whereas there was no significant
difference between serum level of this cytokine in acute cases with both positive IgG and IgM
antitoxoplasma antibodies and serum level in post treatment and control groups  (P= 0.689)
table  figure (1).
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Figure (1): mean of serum IFN Gamma level in different study groups.
Note:*paired t-test between acute (IgM only) group  & post treatment group= 14.256;P=0.000.
** paired t-test between acute (IgM/IgG) group  & post treatment group=0.392;P=0.698.
***Independent t-test between acute group & control group P=0.006.
IL-12 Level.
There was a high significant increase of IL-12 levels (P=0.000) in the sera of patients with
only IgM seropostive toxoplasmosis (81.292±29.278) when compared to that of control group
and post treatment level,whereas level among those with positive IgG and IgM antitoxoplasma
antibodies (15.311±17.595) was statistically lower than post treated group (P=0.000) .The
mean serum level of IL-12 among acute cases was not different statistically from level
registered among control group P=0.16 . (Figure 2)
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Figure (2): mean of serum IL-12 in different study groups.
Note: *paired t-test between acute (IgM only) group  & post treatment group=6.46 ;P value=0.00.
** paired t-test between acute (IgM/IgG) group  & post treatment group.=12.462; P
value=0.000.
***Independent t-test between acute group & control group=1.417;Pvalue=0.16.
HSP-70/IFNγ ratio.
The  study revealed that high production of hSP-70 with concomitant increase of  IFNγ
serum level in patient with IgM seropositive group ,consequently resulting in no significant
difference in ratio (P˃0.05) of HSP-70:IFNγ (0.217) among patients in the early stage of
disease when compared with the ratio for the controlled group (0.45) . (Table-2)
Table (2): The ratio of hsp-70/IFNγ in sera of patients with toxoplasmosis compared with
healthy  control group
Groups
Mean of hsp-70
(Pg/ml)
Mean of IFNγ
(Pg/ml)
Hsp-70/IFNγ
ratio
Control 1.015±0.630 2.211±1.193 0.45
Patients 4.138±1.05847 19.023±1.107 0.217
P value P value ˃0.05
IL-10 Level.
It was obvious that there was a high significant increase in IL-10 level in the sera of patients
with acute toxoplasmosis having both positive IgG and IgM (132.258±97.488pg/ml) when
compared with control and post treated groups (5.331±1.312pg/ml, 6.394±1.591pg/ml). The
same was applied  in acute cases with only positive IgM (14.942±3.539pg/ml) where serum
level was significantly higher than other studied groups (P=0.000). (Figure 3)
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Figure (3): mean of serum IL-10 in different study groups.
Note:*paired t-test between acute (IgM only) group  & post treatment group=7.211; P value=0.000.
** paired t-test between acute (IgM/IgG) group  & post treatment group=6.488 P value=0.000.
***Independent t-test between acute group & control group=4.245 pvalue=0.000.
DISCUSSION:
A high level of  serum concentration of HSP-70 was recorded among patients with ELISA
seropositive of IgM antitoxoplasma antibody (4.138pg/ml) and there was a significant
difference between these level and level in post treated and control groups, whereas serum
level in patient with seropositivity with both IgM&IgG had no significant difference from post
treated group.
The present finding was inconsistent with result found by (19),who concluded that HSP70
have an inhibitory effect on the induction of nitric oxide (NO) release by peritoneal
macrophages of T.gondii-infected mice .Their findings identify HSP70  was danger and lethal
signal during acute T.gondii infection , (19) also concluded that a decrease in NO release in
T.gondii-infected  was correlated with increased parasite replication and decreased cyst
formation. They also found that that there was a reverse relation between HSP70 and IFNγ
level and this finding is incompatible with the finding of present study,    HSP70 induce active
replications and thereby bradyzoites to tachyzoiteses conversion,the reverse will happen in
case of high serum level of IFNγ where these interferon will enhance tachyzoites to
bradyzoites conversion with consequent cyst formation.
However, the current finding was compatible with a more recent finding by (20) who
found that HSP70 induce maturation of bone marrow-derived dendritic cells,they also
demonstrated that IL12 production was enhanced from HSP70-stimulated bone marrow-
derived dendritic cells with cosequent enhancing of IFNγ production ,so there was correlation
between T-Helper-1(Th-1) cytokine concentrations and HSP70 serum level.
Dendritic cells (DCs) are bone-derived professional antigen-presenting cells (APC)
capable of activating naїve antigen-specific T cells and initiating adaptive protective immunity
(21). Dendritic cells maturation is important  to induce T cell activation that plays  a central
role in protective  cellular immunity against intracellular protozoan infection.In peripheral
tissues DCs are found in immature form that are highly effective in acquiring and processing
antigen (22).Dendritic cells ,when exposed to microbial infection ,  will migrate to draining
lymph nodes ,then they will mature into highly potent APCs by up-regulating the expression
of the major histocompatibility complex (MHC) class I and classII molecules and T cell-
stimulatory surface molecules such as CD40,CD80 and CD86 (23), mature DCs present
antigens as processed peptides to naїve CD4 and CD8 cells in drainig lymph nodes (24) and
(25) .
`HSP70-stimulated DCs were capable to produce IL-12 via Toll-like receptor 4(TLR4)
/myloid differentiation factor88(MyD88) thereby modulate T-helper polariztion toward T-
helper type-1 ,this conclusion was compatible with the present result,where there was high
level of HSP70 ,with T-Helper-1(Th1) biase of immune response so the present study revealed
a concomitant increase of Th1 cytokines with the increase of HSP70.
Some researchers found that there will be lack of IL-12 production from HSP70-stimulated
DCs of MyD88-deficient mice which will end in T-Helper-2(Th2) dominance (26; 27) . (28)
and (29) reported that a combination of TLR2 and TLR4 with CD14 induced the MyD88-
independent synergistic augmentation of HSP70-induced proinflammatory cytokine
production ,suggesting that HSP70 might signal by both MyD88-dependent and MyD88-
independent signal pathways .
Regarding to HSP70:IFNγ ratio ,it was obviously that there was no prominent difference in
ratio among   patients in early acute stage of disease and ratio among control group ,indicating
a concomitant increase of both HSP70 and IFNγ,the result was compatible with above
conclusion about the pattern of increase of HSP70 and Th1 cytokine,however no similat
research mentioned or measured such a ratio.
In comparison with present results there was no published data ,available about
relationship of HSP-70 or other  heat shock proteins with T.gondii infection, in Iraq , Arabian
or Islamic countries to compare our results .However these findings   will probably open new
era for researches ,in Iraq and nearby countries, concerning realatioship between HSP70 and
other heat shock proteins , not only with Toxoplasma infection but with other infectious and
non infectious diseases ,moreover   the researches in developed countries  was no so much
about this subject and  its relation with  many diseases  so the current subject is interesting one
and containing many debatable  informations that is  needed to be clarified by further
researches.
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